Results 251 to 260 of about 14,156,764 (395)
Polygenic risk scores in psychiatry: Will they be useful for clinicians? [PDF]
Janice M. Fullerton, John I. Nürnberger
openalex +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Building Information Modeling (BIM): Trends, Benefits, Risks, and Challenges for the AEC Industry
S. Azhar
semanticscholar +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Priority Control of Agricultural and Traffic Sources of Soil Heavy Metals: An Integrated Source-Oriented Risk Assessment in the Drawdown Zone of the Danjiangkou Reservoir. [PDF]
Ding H +11 more
europepmc +1 more source
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad +35 more
wiley +1 more source
The Promises and Pitfalls of Psychedelic Use Among Religious Leaders. [PDF]
Simonsson O, Goldberg SB.
europepmc +1 more source
A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti +3 more
wiley +1 more source
Mercantilist and protectionist shocks on innovation, growth, and economic policy in European regions. [PDF]
McCann P +3 more
europepmc +1 more source

